Corrigendum to "The Story of CD4 (+) CD28(-) T Cells Revisited: Solved or Still Ongoing?".
作者信息
Maly Kathrin, Schirmer Michael
机构信息
Clinic VI, Laboratory of Molecular Biology and Rheumatology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
出版信息
J Immunol Res. 2015;2015:251657. doi: 10.1155/2015/251657. Epub 2015 Jul 8.
Abstract
摘要
相似文献
1
Corrigendum to "The Story of CD4 (+) CD28(-) T Cells Revisited: Solved or Still Ongoing?".《重温CD4(+)CD28(-)T细胞的故事：已解决还是仍在继续？》勘误
J Immunol Res. 2015;2015:251657. doi: 10.1155/2015/251657. Epub 2015 Jul 8.
2
The story of CD4+ CD28- T cells revisited: solved or still ongoing?CD4+ CD28- T 细胞的故事再探讨：解决了还是仍在进行中？
J Immunol Res. 2015;2015:348746. doi: 10.1155/2015/348746. Epub 2015 Mar 5.
3
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus.糖尿病患者中 CD4+CD28null T 淋巴细胞的扩增：探索糖尿病患者心血管风险增加的新发病机制。
Eur Heart J. 2011 May;32(10):1214-26. doi: 10.1093/eurheartj/ehq499. Epub 2011 Jan 8.
4
The proliferative response of HIV+ T-cells (CD4+ and CD8+) are severely suppressed via CD28 coactivation.HIV阳性T细胞（CD4+和CD8+）的增殖反应通过CD28共激活被严重抑制。
Cell Mol Biol (Noisy-le-grand). 1997 Nov;43(7):989-93.
5
Interleukin-15 selectively expands CD57+ CD28- CD4+ T cells, which are increased in active rheumatoid arthritis.白细胞介素-15选择性地扩增CD57+ CD28- CD4+ T细胞，这些细胞在活动期类风湿关节炎中数量增加。
Clin Immunol. 2007 Sep;124(3):328-35. doi: 10.1016/j.clim.2007.06.001. Epub 2007 Jul 23.
6
Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.通过血管细胞黏附分子-1的共刺激可诱导T细胞增强对共刺激分子CD28的配体B7的反应性。
Cell Immunol. 1993 Apr 15;148(1):144-56. doi: 10.1006/cimm.1993.1097.
7
Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease.格雷夫斯病中循环CD4+CD28-T细胞的特征及临床相关性
Immunol Lett. 2015 May;165(1):47-51. doi: 10.1016/j.imlet.2015.03.010. Epub 2015 Mar 31.
8
Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.控制人类CD4+CD28- T细胞激活和外周耐受的共刺激途径。
Eur J Immunol. 1997 May;27(5):1082-90. doi: 10.1002/eji.1830270507.
9
CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients.CX(3)CR1 驱使细胞毒性 CD4(+)CD28(-)T 细胞进入多发性硬化症患者的大脑。
J Autoimmun. 2012 Feb;38(1):10-9. doi: 10.1016/j.jaut.2011.11.006. Epub 2011 Nov 26.
10
Activating NK-cell receptors co-stimulate CD4(+)CD28(-) T cells in patients with rheumatoid arthritis.激活自然杀伤细胞受体可共刺激类风湿关节炎患者的 CD4(+)CD28(-)T 细胞。
Eur J Immunol. 2010 Feb;40(2):378-87. doi: 10.1002/eji.200939399.
引用本文的文献
1
Restored CD8PD-1 T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma.恢复的CD8 PD-1 T细胞有助于胰腺导管腺癌患者对抗PD-1的反应。
Front Oncol. 2022 Apr 11;12:837560. doi: 10.3389/fonc.2022.837560. eCollection 2022.
2
A narrative review of critical factors for better efficacy of CD19 chimeric antigen receptor T cell therapy in the treatment of B cell malignancies.关于CD19嵌合抗原受体T细胞疗法在治疗B细胞恶性肿瘤中提高疗效的关键因素的叙述性综述。
Transl Cancer Res. 2020 Sep;9(9):5655-5662. doi: 10.21037/tcr-20-1044.
3
Predictive significance of T cell subset changes during generation of adoptive cellular therapy products for the treatment of advanced non-small cell lung cancer.过继性细胞治疗产品用于治疗晚期非小细胞肺癌过程中T细胞亚群变化的预测意义
Oncol Lett. 2019 Dec;18(6):5717-5724. doi: 10.3892/ol.2019.10964. Epub 2019 Oct 4.
4
CD28 T lymphocytes of a melanoma patient harbor tumor immunity and a high frequency of germline-encoded and public TCRs.黑色素瘤患者的 CD28 T 淋巴细胞具有肿瘤免疫性和高频的胚系编码及公共 TCR。
Immunol Res. 2018 Feb;66(1):79-86. doi: 10.1007/s12026-017-8976-1.
本文引用的文献
1
The story of CD4+ CD28- T cells revisited: solved or still ongoing?CD4+ CD28- T 细胞的故事再探讨：解决了还是仍在进行中？
J Immunol Res. 2015;2015:348746. doi: 10.1155/2015/348746. Epub 2015 Mar 5.
Zotero 插件